Back
EHRA Premium Access

Amiodarone does not significantly affect the success rate of ventricular fibrillation induction tests performed during or after ICD implantation. Insights from the German DEVICE registry

Session: ePoster session 5
Topic: Implantable Cardioverter-Defibrillator (ICD)
Speaker: Doctor F. Wiedmann (Heidelberg, DE)
Event: EHRA 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Felix Wiedmann

University Hospital Heidelberg, Heidelberg (Germany)
1 presentation
0 follower

7 more presentations in this session

Refinement of voltage-based atrial scar assessment using pacing thresholds and local impedance

Speaker: Doctor A. Bates (Southampton, GB)

Access
Abstract
Slides
Like
Thumbnail

Assessment of scar between atria, rhythms and atrial fibrillation types: does ultra high density mapping offer new insights?

Speaker: Doctor A. Bates (Southampton, GB)

Access
Abstract
Slides
Like
Thumbnail

Cardioneuroablation for the treatment of vasovagal syncope, functional sinus node dysfunction and functional atrioventricular block: initial experience in one center

Speaker: Doctor C. Minguito Carazo (A Coruna, ES)

Access
Abstract
Slides
Like
Thumbnail

Defibrillation test in paediatric patients: should be done?

Speaker: Doctor G. Sarquella Brugada (Barcelona, ES)

Access
Abstract
Slides
Like
Thumbnail

The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation

Speaker: Doctor L. D Angelo (Ancona, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

ePoster session 5

Speakers: Doctor F. Wiedmann, Doctor A. Bates, Doctor A. Bates, Doctor C. Minguito Carazo, Doctor G. Sarquella Brugada...
Access
Like
Thumbnail

About the event

Image

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources